The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ID: ALA4781472
Max Phase: Preclinical
Molecular Formula: C16H16BrN3O4S
Molecular Weight: 426.29
Molecule Type: Unknown
Associated Items:
Representations Canonical SMILES: CNc1cc2onc(C)c2cc1NS(=O)(=O)c1cc(Br)ccc1OC
Standard InChI: InChI=1S/C16H16BrN3O4S/c1-9-11-7-13(12(18-2)8-15(11)24-19-9)20-25(21,22)16-6-10(17)4-5-14(16)23-3/h4-8,18,20H,1-3H3
Standard InChI Key: DVWBDPNOOAMAKK-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Properties Molecular Weight: 426.29Molecular Weight (Monoisotopic): 425.0045AlogP: 3.75#Rotatable Bonds: 5Polar Surface Area: 93.46Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 0CX Acidic pKa: 6.64CX Basic pKa: 3.08CX LogP: 2.06CX LogD: 1.45Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.65Np Likeness Score: -1.65
References 1. Zhang M,Zhang Y,Song M,Xue X,Wang J,Wang C,Zhang C,Li C,Xiang Q,Zou L,Wu X,Wu C,Dong B,Xue W,Zhou Y,Chen H,Wu D,Ding K,Xu Y. (2018) Structure-Based Discovery and Optimization of Benzo[ d]isoxazole Derivatives as Potent and Selective BET Inhibitors for Potential Treatment of Castration-Resistant Prostate Cancer (CRPC)., 61 (7.0): [PMID:29566488 ] [10.1021/acs.jmedchem.8b00103 ]